- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03304535
Social Worker in an Eye-Care Service
The Impact of a Social Worker in a Glaucoma Eye-Care Service: A Prospective Study
Study Overview
Status
Conditions
Detailed Description
An appointment will be scheduled for participant to meet with a social worker. The appointment may happen on day of participant's scheduled clinic appointment or on another mutually decided upon date and time. Should participant choose to participate, this first visit will be Visit 1 for the study.
Visit 1: Baseline
Informed consent will be obtained demonstrating an interest in participating.
A visit with the social worker will take place during Visit 1. This session will be held in a private office and allows participant time for discussion regarding any challenges, struggles and/or barriers they may be experiencing.
The following baseline questionnaires/surveys will be administered:
Modified Patient Activation Measure - measures participant confidence in taking care of their own health.
Distress Thermometer - measures participant distress level during the past week.
Patient Health Questionnaire -measures depression symptoms and severity if any.
Clinical information will be taken from participant's medical record. There may be follow-up questions related to data if information is unclear or incomplete.
Upon completion of Visit 1, participant will receive a satisfaction survey to evaluate how participant satisfaction with social worker interaction.
Social Worker Interventions: After Visit 1 and before Visit 2
The social worker will develop an intervention for participant during Visit 1 appointment. As many calls or in person meetings participant requires will take place. There will be no limit and it will be determined by participant's needs.
Visit 2: Follow-up After 6 Months
Upon completion of participant's six month follow-up in the study, the following questionnaires/surveys will be administered:
Modified Patient Activation Measure - measures how confident participant is at taking care of their own health.
Distress Thermometer - measures how much distress participant has been experiencing in the past week.
Patient Health Questionnaire - measures if participant has symptoms of depression and the severity of those symptoms.
Satisfaction Survey - measures how satisfied participant is with the social worker interaction.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19107
- Wills Eye Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients seen at Wills Eye Hospital in the Glaucoma Service
- Glaucoma of any type, characterized by glaucomatous optic neuropathy and corresponding visual field (VF) defect
- Referred to staff social worker for intervention
- Ability to read, write, speak and understand English
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in response to Patient Health Questionnaire 9
Time Frame: 6 months
|
Measures participant levels of depression based on questions related to depressive symptoms.
The investigator will assess change in the number of participants with major, moderate, and minimal depressive symptoms.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in response to Distress thermometer
Time Frame: 6 months
|
Measures participant level of distress on a scale of 1 to 10 and asks additional questions regarding contributors to distress.
|
6 months
|
|
Change in response to Modified Patient Activation Measure 13
Time Frame: 6 months
|
Measures participant self-capacity for and confidence regarding glaucoma management.
|
6 months
|
|
Descriptive results of the Social Worker Baseline Assessment
Time Frame: 6 months
|
Social worker will assess each participant's internal and external barriers to care, limitations, and strengths that may help them to manage their glaucoma.
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Scott J Fudemberg, MD, Wills Eye Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB#15-XXX
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glaucoma
-
Hospices Civils de LyonRecruitingOpen-angle Glaucoma | Glaucoma Eye | Pigmentary Glaucoma | Closed-Angle Glaucoma | Pseudo Exfoliative SyndromeFrance
-
Imperial College Healthcare NHS TrustIRIDEX CorporationNot yet recruitingGlaucoma | Glaucoma, Open-Angle | Glaucoma, Angle-Closure | Glaucoma, Neovascular | Glaucoma Eye | Glaucoma Secondary | Glaucoma Traumatic | Glaucoma Uveitic
-
Wills EyeIOP OphthalmicsTerminatedPrimary Open Angle Glaucoma | Neovascular Glaucoma | Uveitic Glaucoma | Pseudoexfoliation Glaucoma | Primary Angle Closure Glaucoma | Pigmentary Glaucoma | Traumatic GlaucomaUnited States
-
Isfahan University of Medical SciencesActive, not recruitingAngle Closure Glaucoma | Glaucoma EyeIran
-
University of MiamiAbbVieRecruitingOcular Hypertension | Glaucoma | Open-Angle Glaucoma | Glaucoma SuspectUnited States
-
Centre hospitalier de l'Université de Montréal...CompletedGlaucoma | Glaucoma, Open-Angle | Glaucoma, Neovascular | Glaucoma Eye | Glaucoma and Ocular Hypertension | Glaucoma, Uncompensated | Glaucoma SecondaryCanada
-
Ngoc Nguyen Inc.Alcon ResearchNot yet recruitingGlaucoma | Glaucoma, Open Angle | Open Angle Glaucoma (OAG) | Normal Tension Glaucoma (NTG)United States
-
Pro Top & Mediking Company LimitedCompletedOpen Angle Glaucoma | Neovascular Glaucoma | Angle Closure Glaucoma | Uveitis Glaucoma | Young Age Glaucoma | High Risk PatientEstonia
-
Stanford UniversityNot yet recruitingPrimary Open Angle Glaucoma | Open Angle Glaucoma | Low Tension Glaucoma | Pseudoexfoliation Glaucoma | Pigmentary GlaucomaUnited States
-
Henry Ford Health SystemNot yet recruitingPrimary Open Angle Glaucoma (POAG) | Secondary Open Angle Glaucoma | Open Angle Glaucoma (OAG)United States